Developing Low-Cost Universal Malnutrition Screening for Low Income Countries - the MAMMS Trial
Launched by UNIVERSITY OF WASHINGTON · May 25, 2019
Trial Information
Current as of May 07, 2025
Unknown status
Keywords
ClinConnect Summary
Acute malnutrition is a critical driver of pediatric mortality that must be addressed to achieve global child health targets. Provision of ready-to-use therapeutic foods (RUTF) and nutritional counselling in the community is a highly effective method of preventing deaths among malnourished children. However, UNICEF estimates that only 17% of malnourished children receive treatment. Among children who are treated, the diagnosis of acute malnutrition is often made late in their disease when the risk of complications and death increases from 2.5% to 16%. Increasing the coverage and frequency o...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Infant is 6-12 months of age and MUAC of 12.5-14.0 cm
- • Access to a mobile phone and can provide a mobile phone number
- • Planning to remain in the catchment area more than 6 months and willing to return for 6-month follow up visit
- • Mother is willing to be randomized to weekly SMS and measure and send weekly infant MUAC via SMS
- • Able to read or write or has someone to help them read or write
- Exclusion Criteria:
- • Infant is currently on treatment for malnutrition
- • Inability to provide a mobile phone number
- • Mothers that could not read or write and did not have someone to help them read or write
About University Of Washington
The University of Washington (UW) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust network of interdisciplinary teams, UW fosters collaboration among top-tier researchers, clinicians, and healthcare professionals, aiming to translate scientific discoveries into impactful treatments and interventions. The university is dedicated to ethical research practices and participant safety, ensuring rigorous adherence to regulatory standards in all clinical trials. Through its state-of-the-art facilities and extensive expertise, UW strives to address pressing health challenges and improve patient outcomes on a local and global scale.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Homa Bay, , Kenya
Macalder, , Kenya
Migori, , Kenya
Patients applied
Trial Officials
Christine J McGrath, PhD, MPH
Principal Investigator
University of Washington
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials